Biotech makes a $303M run on Wall Street; Billionaire Thiel backs a startup round for antibiotic developer
⇨ It’s been another big week on the biotech IPO front. Deciphera $DCPH went public, raising $128 million for its solid tumor work, sticking …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
